MS Speaks

Multiple Sclerosis => TREATMENTS => Topic started by: agate on March 29, 2018, 02:49:13 pm

Title: Medscape MS drug update: Tysabri, ibudilast, daclizumab
Post by: agate on March 29, 2018, 02:49:13 pm

Neurologist Dr. Stephen Krieger gives an update on MS drug research information, touching on the natalizumab dosing schedule change, the potential for ibudilast to treat SPMS, and the withdrawal from the market of daclizumab:


https://www.medscape.com/viewarticle/894238